Loading organizations...
§ Venture Capital · Boston, MA, USA
Whittier Ventures operates as a venture capital investment firm, channeling capital and expertise into the healthcare sector. It actively identifies and supports early-stage companies focused on developing innovative healthcare devices and specialized software solutions. The firm applies a strategic approach to fostering technological advancements that promise to reshape medical practices and patient care.
Founded in 1996, Whittier Ventures originated from a keen understanding of the critical need for dedicated investment in the evolving healthcare technology landscape. Its establishment was driven by an insight into the burgeoning opportunities for disruptive solutions in medical diagnostics and therapeutic tools. The firm initially planted its roots in Reno, Nevada, positioning itself to capitalize on emerging trends in this vital industry.
Whittier Ventures serves as a financial and strategic partner for companies pioneering new healthcare products and services, guiding them through development and market entry. The firm's portfolio reflects a commitment to entities capable of delivering significant improvements in health outcomes and operational efficiencies within the medical field. Whittier Ventures envisions a future where its targeted investments contribute to a healthier society through sustained technological innovation.
Whittier Ventures has 3 tracked investments across 2 companies. The latest tracked deal is $15.0M Series C in NeuroVision Imaging in May 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 2, 2018 | NeuroVision Imaging | $15.0M Series C | Wildcat Capital Management | Johnson & Johnson Innovation, Nikon SBI Innovation Fund, VSP Global |
| Jan 9, 2017 | SnapMD | $3.2M Series A Extension | — | Shea Ventures, TYLT Ventures |
| Jan 28, 2016 | SnapMD | $5.3M Series A | — | Shea Ventures, TYLT Ventures |